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Background: Infants may be at risk of hypoglycaemia in the perioperative period. Current evidence has led to the global use 
of maintenance fluid with low-concentration dextrose in these patients. This study aimed to analyse the current practice of 
anaesthetists in the authors’ institution with regard to blood glucose management, and to assess its adequacy.
Methods: Ninety-nine patients under one year of age, or less than 10 kilograms, who required anaesthesia were enrolled. The 
intraoperative management of intravenous dextrose administration and blood glucose monitoring was at the discretion of the 
attending anaesthetists. Data collected included patient demographics, period of starvation, dose of dextrose administered and 
blood glucose measurements taken.
Results: Nine infants had at least one glucose value lower than 3.7 mmol/l at any time during the procedure, while all received 
intravenous dextrose intraoperatively. The hypoglycaemic episode occurred on initial measurement (start of surgery) in five 
infants and later on in the procedure in four infants. This subgroup had an average age of 1.5 months, and average weight of 
2.9 kg. Seven of these infants had significant co-morbidities and/or prematurity and low birthweight.
Conclusions: The findings indicate that anaesthetists adhere to current recommendations regarding glucose management, and 
confirmed the safety of intraoperative administration of 0–2.5% dextrose in isotonic solution to healthy infants. The authors’ 
observations also emphasised that smaller infants and those with significant co-morbidities are at particular risk of developing 
hypoglycaemia, despite preoperative and intraoperative dextrose administration. It remains important to check glucose levels 
in patients at risk of hypoglycaemia.
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Introduction
During fasting, hypoglycaemia develops earlier in younger 
children, as was borne out in an analysis of children between 0 
and 18 years of age.1 Children have low glycogen stores in the 
liver, which results in a rapid decrease in endogenous glucose 
production (EGP). This explains why in particular children 
younger than three  years experience hypoglycaemia more 
readily than adults do during periods of fasting.2
The brain derives 90% of its energy from glucose during times of 
fasting and the ratio of a baby’s brain-to-body weight is six times 
higher than that of an adult: the brain of a 3 kg newborn weighs 
400 g, while an adult’s brain weighs 1400 g.2 This may partially 
explain why infants have an EGP of 5–8 mg/kg/min, as opposed 
to adults’ 2–3 mg/kg/min.3,4
Limited adaptation of glucose metabolism is particularly evident 
in preterm infants. They have very low liver glycogen stores, as 
well as immature gluconeogenic enzymes and hormonal 
responses.5 A prospective study showed that up to 20% of 
preterm infants who were ready for discharge were still at risk of 
hypoglycaemia when a feed was delayed.5
Children and neonates are at particular risk of hypoglycaemia 
when suffering from sepsis (shown with malaria, diarrhoea, 
pneumonia, meningococcal disease), and neonates may 
additionally suffer hypoglycaemia in association with asphyxia 
and hypothermia.2,3,5,6 In contrast, surgery and critical illness may 
cause hyperglycaemia.3
Hypoglycaemia can affect neurodevelopmental outcome.3,4 
Hyperglycaemia may also be harmful to the nervous system, 
especially when associated with ischaemia or hypoxia, and may 
additionally lead to an osmotic diuresis with subsequent 
dehydration.7
Careful glucose management is therefore required in neonates 
and small infants, especially in infants with co-morbidities. Under 
anaesthesia the metabolic rate, and therefore demand, decreases 
while the stress response leads to an increase in endogenous 
glucose production. It was shown that giving 0.9% or 1% dextrose 
in Ringer’s lactate as maintenance in anaesthetised children 
maintained glucose levels, and even improved glucose levels in 
some hypoglycaemic patients, without causing hyperglycaemia.8 
The Association of Paediatric Anaesthetists of Great Britain and 
Ireland’s guidelines on perioperative fluid management do not 
recommend that dextrose-containing maintenance fluid be 
given to healthy infants, and that infants at risk of hypoglycaemia 
be monitored intraoperatively while dextrose can be added to 
maintenance fluid.9 Others, including the European Association of 
Paediatric Anaesthetists, recommend the use of an isotonic 
maintenance solution containing 1–2.5% dextrose for infants.10,11
Our institution has no set protocol to guide the administration of 
intravenous glucose to patients in theatre, but it is recommended 
that at least one glucose measurement be taken intraoperatively 
in small infants, and glucose is monitored in critically ill children 
or children undergoing prolonged surgical procedures. We were 
confident that our clinicians adhered to acceptable practice, but 
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we expected to find a number of hypoglycaemic patients. Our 
study aimed to collect data on the current practice of clinicians 
regarding intraoperative glucose supplementation, and to 
investigate whether it results in acceptable glucose levels.
Methods
This observational study was done following institutional review 
board approval. All infants under one year of age, or weighing less 
than ten kilograms, who required any procedure under anaesthesia 
in theatre were eligible. Informed consent was obtained from a 
parent or legal guardian and the following data were collected: 
patient age, weight, presence of prematurity and post-conceptional 
age where applicable, procedure planned, co-morbidities, duration 
of starvation (for solids, breast milk and clear fluids respectively), 
duration of surgery, administration of intravenous maintenance 
fluid preoperatively, volume of intravenous fluids and dose of 
intravenous dextrose given intraoperatively (both boluses and 
infusions), and glucose values measured. Capillary blood glucose 
measurements were done via either HemoCue Glucose 201® 
(HemoCue AB, Ängelholm Sweden) or Accu-Chek Active® (Roche 
Diabetes Care, Burgess Hill, UK) systems.
Anaesthetists were instructed to follow their normal practice 
regarding dextrose administration and blood glucose 
monitoring. The concentration and volume of intravenous 
dextrose administered, the timing of blood glucose 
measurements and the response to these measurements was at 
the full discretion of the anaesthetist in charge of that patient. 
Anaesthetists were required to record all measurements and 
interventions on the data collection sheet. The only instruction 
to anaesthetists was to do a minimum of one glucose 
measurement at the conclusion of the procedure.
Results
One hundred infants were enrolled, but one was excluded 
because insufficient data had been recorded. The characteristics 
of the study group are summarised in Table 1.
The average (range) duration of starvation was 16.2 (3.5–48), 6.2 
(1–13.5) and 4.3 (2–9.5) hours for solids/formula, breast milk and 
clear fluids respectively. Twelve infants were starved for longer 
than 9 h without receiving intravenous fluids preoperatively, and 
the longest time of starvation without preoperative 
administration of intravenous fluid was 15 h. Starvation 
information was not recorded in two cases.
Figure 1 depicts intraoperative dextrose administration. Thirty 
infants received no dextrose, 62 received less than 200 mg/kg/
hour dextrose (averaged over the duration of the surgery) and 
seven received more than 200 mg/kg/hour. In Table 2 data from 
these seven patients are summarised. Of the seven, five were 
administered a bolus of intravenous dextrose. In four cases this 
was in response to a blood glucose measurement < 3.7 mmol/l 
during the procedure as shown in the table. Two cases (35, 41) 
received boluses without infusions for very short procedures 
(15–30 min). All cases except patient no. 77 were emergency 
cases. One infant (77) was maintained on the 10% dextrose 
infusion he had been on preoperatively. The average (range) 
blood glucose value at the end of surgery in these seven infants 
was 6.9 (3.0–9.1) mmol/l. The 92 infants who received 0–200 mg/
kg/hr dextrose had an average (range) glucose measurement of 
7.5 mmol/l (3.5–16.2) at the end of surgery.
The composition of the maintenance fluid selected by our 
anaesthetists consisted of 0–2.5% dextrose in isotonic solution in 
96 of the patients. Of the three that received higher 
concentrations, two had been on preoperative intravenous 
maintenance, and were continued on it. The third patient was an 
ex-premature infant who had been starved for 11 h before 
surgery. The percentage dextrose mixed into isotonic crystalloid, 
given as intravenous maintenance fluid to the 99 patients, can be 
seen in Figure 2. This excludes intravenous dextrose boluses.
Table 1: Characteristics of study group (n = 99)
Note: Values are expressed as: mean (range) or absolute numbers.
Characteristic n
Age (months) 5.1 (0–19.5)
Weight (kg) 5.4 (0.75–12.6)
Ex-premature (number) 24
Post-conceptual age if ex-premature (weeks) 42 (30–64)
Emergency surgery (number) 33





Dextrose < 200 mg/kg/hr
Dextrose > 200 mg/kg/hr
Figure 1: Intraoperative dextrose administration by anaesthetists.
Table 2: Patients receiving > 200 mg/kg/hr of dextrose intraoperatively



















13 3 No 527.0 2% 10% 3.0 End of surgery 3.0
26 5 Yes 523.3 1% 10% 2.2 Start of surgery 7.4
35 9 No 774.2 Nil 2% 2.4 Start of surgery 4.3
41 6 Yes 259.7 Nil 2% 6.8 6.8
49 9 Yes 295.5 2% 5%, 2%, 2.5% 3.6 During surgery 4.1
56 24 Yes 276.3 10% Nil 4.4 4.4
77 11 No 285.7 5% Nil 7.4 9.1
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In total 140 blood glucose measurements were done in the 99 
enrolled infants. The distribution of these measurements is 
depicted in Figure 3. These include measurements done at the 
start of the procedure, during the procedure and the obligatory 
measurement at the end of the procedure. Nine infants had at 
least one glucose measurement reading lower than 3.7 mmol/l 
at any time during the procedure, despite all of them receiving 
intravenous dextrose for the duration of the anaesthetic. The 
characteristics of these patients are presented in Table 3. This 
subgroup had an average age of 1.3 months and average weight 
of 2.9 kg. Four of them had been born prematurely, and two were 
born at term but had low birthweights. Seven babies had 
significant co-morbidities (with or without prematurity and low 
birthweight). In five of these nine infants, the lowest blood 
glucose value was recorded at the start of the procedure, and 
three of these measurements were below 2.6 mmol/l. In two of 
the nine patients, the lowest blood glucose value was recorded 
during the procedure, and in the other two patients only one 
measurement was done (at the end of the procedure).
Six of these infants with hypoglycaemia received intravenous 
dextrose maintenance infusions preoperatively. Of the three 
infants with a starting blood glucose value of less than 2.6 mmol/l, 
two did not receive any preoperative intravenous dextrose 
despite both infants being fasted for nine hours preoperatively.
Discussion
Normal glucose values
Hyperglycaemia can be defined in terms of diabetes, which is 
diagnosed in children if the fasting glucose is 7.0  mmol/l or 
higher, or the post-oral glucose challenge value is 11.1 mmol/l or 
higher.12 Determining the lower limit of normal for glucose 
values in infants is more difficult.
Children under 24 months have lower non-fasting glucose values 
than older children.1 Glucose values as low as 2.2 mmol/l have 
been used as cut-off for ‘hypoglycaemia’.1,2 Another suggestion is 
a cut-off of 2.5  mmol/l for neonates,2,4 3.0  mmol/l for older 
children, and 3.9 mmol/l for adults.2 Determination of a cut-off 
value could be based on an epidemiologic approach (based on 
values attained from a cohort), a clinical approach (hypoglycaemia 
diagnosed by the presence of symptoms), a neurophysiological 
approach (looking at effects on, for example, somatosensory 
evoked potentials), a metabolic/endocrine based approach, or a 










Figure 2: Number of patients who received various concentrations of 










Figure 3: Distribution of all intraoperative blood glucose (in mmol/l) 
measurements obtained.
Table 3: Patients with a glucose measurement less than 3.7 mmol/l
Note: NR = not recorded.
Patient 
no.
Age (m) Weight 
(kg)
















3 2.00 3.2 Yes Cyanotic heart disease, 
severe sepsis
3.5 Yes 46.9 3.3 Start of surgery 3.6
8 3.50 2.8 No Arthrogryposis multi-
plex congenita
9 No 190.5 2.4 Start of surgery 4.5
13 0.07 2.3 No Low birthweight, foetal 
alcohol exposure
3.25 No 527.0 3.0 End of surgery 3.0
26 2.50 2.79 No Low birthweight, 
laryngeal cleft, aspira-
tion pneumonia, poor 
growth
5 Yes 523.3 2.2 Start of surgery 7.4
35 0.80 3.1 No Nil 9 No 774.2 2.4 Start of surgery 4.3
36 0.13 2.3 Yes Nil NR Yes 173.9 3.2 During surgery 4.1
49 0.93 4.4 No Renal failure, hypoplas-
tic lungs secondary to 
oligohydramnios, PDA
9 Yes 295.5 3.6 During surgery 4.1
84 2.00 3.4 Yes Liver failure 12 Yes 121.1 3.5 End of surgery 3.5
100 0.03 1.8 Yes Acute abdomen 24 Yes 188.9 3.3 Start of surgery 5.7
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Interpretation of any glucose value should take into account the 
accuracy of the measurement. Measurements taken with point-
of-care devices can differ from the true values by as much as 
1.1 mmol/l, especially at low glucose values. Other factors that 
can influence accuracy include a high haematocrit, 
hyperbilirubinemia and acidosis.14 Therefore a cut-off value for 
hypoglycaemia set at 3.6 mmol/l may be safest.
Using this cut-off value, we report hypoglycaemia in nine of our 
patients. Of these patients, six had a lowest recorded 
measurement between 3.0 and 3.6  mmol/l, two had a 
measurement of 2.4  mmol/l, and one had a measurement of 
2.2 mmol/l.
Dextrose concentration in maintenance
It is estimated that term neonates need a dextrose infusion of 
3–4 mg/kg/min (180–240 mg/kg/hr) to prevent hypoglycaemia.15 
This is in keeping with the utilisation of 5% dextrose-containing 
maintenance fluid. In 1931 Karelitz and Schick described using a 
5% dextrose solution to treat dehydrated children while 
preventing hypoglycaemia. Holliday and Segar’s 
recommendation for maintenance fluid also contained 5% 
dextrose. Infants do suffer a stress response to surgery, though, 
and a study by Welborn et al. in 1986, as well as other studies, 
showed that adding 5% dextrose to maintenance solutions can 
cause significant hyperglycaemia intraoperatively.16 Infusions of 
solutions containing 0–2.5% dextrose therefore grew in 
acceptance, and are now part of guidelines issued by various 
anaesthetic societies (as mentioned earlier).
This stress response is also relevant postoperatively. In an intensive 
care study Verbruggen et al. assigned eight infants to either 150 or 
300  mg/kg/hr dextrose maintenance infusions after surgery for 
craniosynostosis. Patients receiving 300  mg/kg/hr were 
hyperglycaemic, while the group receiving 150  mg/kg/hr were 
normoglycaemic without suffering more protein catabolism.17
Running a 2.5% dextrose solution (as per current 
recommendation) at 4  ml/kg/hr will deliver 100  mg/kg/hr 
glucose.
Hypoglycaemic patients
Our observations emphasise that certain individuals are at 
higher risk of hypoglycaemia than others. In keeping with the 
literature, we noted hypoglycaemia in ex-premature infants, 
patients with low birthweight, and patients with significant co-
morbidities. Administration of preoperative intravenous 
maintenance fluid containing dextrose was not protective 
against hypoglycaemia in six of the nine patients who developed 
hypoglycaemia, despite the administration of intraoperative 
intravenous dextrose, and should therefore not be relied upon to 
prevent hypoglycaemia.
Conclusion
The importance of individual blood glucose monitoring in 
children, as well as the risks to patients with ex-prematurity or 
low birthweight, and significant co-morbidities are emphasised.
Most anaesthetists in this study administered low-concentration 
dextrose, as recommended by literature. We confirmed that 
administration of 0–2.5% dextrose in isotonic solution as 
intravenous maintenance fluid intraoperatively results in 
acceptable glucose levels in most healthy infants, and that it may 
even be associated with hyperglycaemia.
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